Mazyar Shadman, MD, MPH
Associate Professor
Clinical Research Division, Fred Hutch
Innovators Network Endowed Chair
Fred Hutch
Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia, or CLL, as well as immunotherapy (specifically CAR T cell therapy) for lymphoid neoplasms and blood stem cell transplant for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.
Other Appointments & Affiliations
Medical Director, Bezos Family Immunotherapy Clinic, Fred HutchMedical Director, Bezos Family Immunotherapy Clinic
Fred Hutch
Affiliate Investigator
Translational Science and Therapeutics Division, Fred Hutch
Associate Professor, Medical Oncology Division
University of Washington School of Medicine
Education
Hematology and Medical Oncology fellowship, University of Washington/Fred Hutchinson Cancer Center, 2011-2014
Internal Medicine Residency, Cleveland Clinic, 2008-2011
MPH, Cancer Epidemiology, University of Washington, 2008
MD, Tehran University of Medical Sciences, 2004
Research Interests
Therapeutic clinical trials in lymphoid malignancies with a focus on chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Clinical outcome research in hematopoietic cell transplantation
Epidemiology of hematologic malignancies
"My goal is to really bring what happens in the lab to the patient level, taking the research that is created by scientists at Fred Hutch and translating that to the patient."
— Dr. Mazyar Shadman